Karin Welen
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.
Journal: Scientific reports
Published: January 29, 2026
SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 04, 2025
Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis.
Journal: Clinical & experimental metastasis
Published: April 10, 2025
Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer
Journal: Lakartidningen
Published: April 24, 2024
Acoustic enrichment of heterogenous circulating tumor cells and clusters from patients with metastatic prostate cancer.
Journal: medRxiv : the preprint server for health sciences
Published: December 18, 2023
Magnetic Resonance Imaging as a Tool for Monitoring Intratibial Growth of Experimental Prostate Cancer Metastases in Mice.
Journal: Methods and protocols
Published: September 28, 2023
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 15, 2023
Androgens, aging, and prostate health.
Journal: Reviews in endocrine & metabolic disorders
Published: April 22, 2022
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study.
Journal: BMJ open
Published: February 15, 2022
Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients.
Journal: European urology
Published: February 05, 2022
Osteoclasts directly influence castration-resistant prostate cancer cells.
Journal: Clinical & experimental metastasis
Published: February 04, 2022
Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93.
Journal: European urology
Published: January 24, 2022
Last Updated: 09/26/2026